Michael D. West - 11 Mar 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Reporting relationship: Chief Executive Officer
Issuer ticker: SER
Reported as of: 11 Mar 2023
Net transaction value: -$625
SEC form: 4
Accepted by SEC: 14 Mar 2023, 21:32:33 UTC
Prior SEC filing: 13 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/Michael D. West

Filing notes and source

Key filing fact

Michael D. West filed Form 4 for AgeX Therapeutics, Inc. (SER) on 14 Mar 2023.

Key facts

This page summarizes Michael D. West's Form 4 filing for AgeX Therapeutics, Inc. (SER).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Mar 2023, 21:32.

Change

Previous filing in this sequence was filed on 13 Dec 2022.
Current net transaction value: -$625.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGE transaction

Common Stock, $0.0001 par value

Options Exercise

Transaction value: $0
Shares: +3,125
Change %: +7.8%
Price: $0.000000
Shares after: 43,042
Date: 11 Mar 2023
Ownership: Direct
Footnotes: F1

AGE transaction

Common Stock, $0.0001 par value

Tax liability

Transaction value: $625
Shares: -1,060
Change %: -2.5%
Price: $0.5900
Shares after: 41,982
Date: 11 Mar 2023
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGE transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -3,125
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,125
Exercise price: $0.000000
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership.

Footnote F2

Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.

Footnote F3

Restricted Stock Units vested on March 11, 2023.